{
  "project_id": "tnaas-HDAC6-v2-benchmark",
  "target": {
    "symbol": "HDAC6",
    "name": "HDAC6",
    "uniprot": "Q9UBN7",
    "organism": "Homo sapiens"
  },
  "indication": "Cancer (Multiple Myeloma); Mechanism relevant for Neurodegeneration",
  "mechanism_of_action": "Benchmark: selective HDAC6 inhibitors",
  "modality": "Benchmark dataset",
  "context_of_use": "benchmark",
  "known_risks": "This is a synthetic benchmark placeholder; integrate real evidence before deployment.",
  "evidence_positive": [
    "HDAC6 inhibitors: ricolinostat IC50 variable by cell line, citarinostat IC50 2.6nM (HDAC6); induces \u03b1-tubulin acetylation; synergistic with paclitaxel in breast cancer"
  ],
  "evidence_negative": [],
  "retrieved_at": "2025-11-10T09:42:46.973750+00:00",
  "truth_row": {
    "dg_expected_min_kcal": "-9.5",
    "dg_expected_max_kcal": "-7.0",
    "bbb_expected_band": "pass",
    "cns_mpo_expected_min": "1.0",
    "herg_expected_band": "watch",
    "cyp_expected_band": "watch",
    "dili_expected_band": "pass",
    "pdb_expected_min": "3"
  }
}
